We found that ATG4B exhibited significantly high expression levels in various acute myeloid leukemia (AML) with diverse molecular subgroups (e.g., MLL‐rearrangement, FLT3‐ITD mutation, and NPM1 mutation, etc.)(Figure6A; Figure S5A–C, Supporting Information). This evidence concerns the gene KMT2A and acute myeloid leukemia.